Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A22027 | 24868320 | World J Hepatol | Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. | 2014 | Details |
A22030 | 24866317 | Rev Med Inst Mex Seguro Soc | [Nonalcoholic fatty liver disease in children]. | 2014 | Details |
A22032 | 24864249 | Biomed Res Int | Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease. | 2014 | Details |
A22033 | 24864199 | J Obes | Lifestyle intervention involving calorie restriction with or without aerobic exercise training improves liver fat in adults with visceral adiposity. | 2014 | Details |
A22035 | 24861033 | Dig Dis Sci | Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects. | 2014 | Details |
A22039 | 24857839 | Arch Biochem Biophys | Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis. | 2014 | Details |
A22040 | 24857364 | J Agric Food Chem | Garlic essential oil protects against obesity-triggered nonalcoholic fatty liver disease through modulation of lipid metabolism and oxidative stress. | 2014 | Details |
A22048 | 24851523 | Trop Gastroenterol | Profile of patients with incidentally detected nonalcoholic fatty liver disease (IDNAFLD) in coastal eastern India. | 2014 | Details |
A22049 | 24850609 | Georgian Med News | [Effect of gene polymorphism of PPARgamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity]. | 2014 | Details |
A22058 | 24847614 | Cent Eur J Public Health | Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study. | 2014 | Details |
A22063 | 24845056 | Hepatology | Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. | 2014 | Details |
A22064 | 24844310 | Eat Weight Disord | Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children? | 2014 | Details |
A22067 | 24843703 | J Diabetes Investig | Role of thiazolidinediones, insulin sensitizers, in non-alcoholic fatty liver disease. | 2013 | Details |
A22068 | 24843689 | J Diabetes Investig | Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines. | 2013 | Details |
A22069 | 24842304 | J Hepatol | Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia. | 2014 | Details |
A22071 | 24841950 | Obes Surg | The diagnostic accuracy of transient elastography for the diagnosis of liver fibrosis in bariatric surgery candidates with suspected NAFLD. | 2014 | Details |
A22073 | 24838722 | BMJ Open | Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study. | 2014 | Details |
A22077 | 24834836 | Biol Rev Camb Philos Soc | Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease. | 2014 | Details |
A22078 | 24834820 | Environ Res | Secondhand tobacco exposure is associated with nonalcoholic fatty liver disease in children. | 2014 | Details |
A22081 | 24830635 | Horm Metab Res | Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling. | 2014 | Details |
A22082 | 24830603 | Exp Mol Pathol | Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes. | 2014 | Details |
A22083 | 24830559 | Int J Mol Sci | Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. | 2014 | Details |
A22086 | 24829701 | Middle East J Dig Dis | Oral Nitrate Reductase Activity Is Not Associated with Development of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Pilot Study. | 2014 | Details |
A22088 | 24829682 | Middle East J Dig Dis | Probiotics and Nonalcoholic Fatty liver Disease. | 2013 | Details |
A22089 | 24829591 | Hepat Mon | Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". | 2014 | Details |
A22099 | 24823873 | Diabetes Metab Res Rev | Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes. | 2014 | Details |
A22103 | 24819229 | Metab Syndr Relat Disord | Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women. | 2014 | Details |
A22106 | 24816727 | J Physiol Biochem | Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion. | 2014 | Details |
A22107 | 24816278 | PLoS One | Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model. | 2014 | Details |
A22111 | 24814684 | Metabolism | De novo lipogenesis in health and disease. | 2014 | Details |
A22113 | 24812009 | Toxicol Sci | Human receptor activation by aroclor 1260, a polychlorinated biphenyl mixture. | 2014 | Details |
A22114 | 24811405 | Appl Microbiol Biotechnol | Preventing non-alcoholic fatty liver disease through Lactobacillus johnsonii BS15 by attenuating inflammation and mitochondrial injury and improving gut environment in obese mice. | 2014 | Details |
A22117 | 24803983 | Oxid Med Cell Longev | BL153 partially prevents high-fat diet induced liver damage probably via inhibition of lipid accumulation, inflammation, and oxidative stress. | 2014 | Details |
A22121 | 24799990 | World J Hepatol | Pediatric non-alcoholic fatty liver disease: New insights and future directions. | 2014 | Details |
A22122 | 24799988 | World J Hepatol | Insulin sensitizers for the treatment of non-alcoholic fatty liver disease. | 2014 | Details |
A22123 | 24799987 | World J Hepatol | Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease. | 2014 | Details |
A22124 | 24799985 | World J Hepatol | Lipid lowering effects of iodothyronines: In vivo and in vitro studies on rat liver. | 2014 | Details |
A22127 | 24797980 | Adv Med Sci | Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease. | 2014 | Details |
A22128 | 24797780 | Cas Lek Cesk | [Relation of risk factors between metabolic syndrome and nonalcoholic fatty liver disease in children and adolescents]. | 2014 | Details |
A22133 | 24796105 | Nihon Rinsho | [Liver diseases]. | 2014 | Details |
A22135 | 24795720 | Front Immunol | Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools. | 2014 | Details |
A22142 | 24793347 | J Clin Lipidol | Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy. | 2014 | Details |
A22145 | 24791843 | Med Ultrason | Comparison between the M and XL probes for liver fibrosis assessment by transient elastography. | 2014 | Details |
A22146 | 24789994 | Am J Physiol Regul Integr Comp Physiol | Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity. | 2014 | Details |
A22151 | 24786095 | Int J Mol Sci | Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). | 2014 | Details |
A22154 | 24784707 | Mol Cell Endocrinol | Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells. | 2014 | Details |
A22155 | 24783906 | Med Arch | Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods. | 2014 | Details |
A22158 | 24782263 | Semin Liver Dis | Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) study. | 2014 | Details |
A22165 | 24775093 | J Nutr Biochem | Diets enriched in trans-11 vaccenic acid alleviate ectopic lipid accumulation in a rat model of NAFLD and metabolic syndrome. | 2014 | Details |
A22166 | 24772746 | J Assoc Physicians India | Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). | 2013 | Details |
A22172 | 24768828 | J Hepatol | Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: the ALSPAC study. | 2014 | Details |
A22174 | 24768200 | Med Clin (Barc) | [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity]. | 2014 | Details |
A22175 | 24766485 | Clin Sci (Lond) | Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin-resistant high-fat-diet-fed foz/foz mice. | 2014 | Details |
A22179 | 24765505 | Clin Pract | Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease. | 2013 | Details |
A22180 | 24764677 | World J Gastroenterol | Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial. | 2014 | Details |
A22182 | 24763885 | Eur Rev Med Pharmacol Sci | Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease. | 2014 | Details |
A22183 | 24763757 | PLoS One | Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic fatty liver disease. | 2014 | Details |
A22185 | 24760992 | Am J Physiol Endocrinol Metab | Mice lacking NOX2 are hyperphagic and store fat preferentially in the liver. | 2014 | Details |
A22189 | 24758604 | BMC Gastroenterol | NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease. | 2014 | Details |
A22191 | 24758097 | Invest Clin | [Hepatic steatosis, visceral fat and metabolic alterations in apparently healthy overweight/obese individuals]. | 2014 | Details |
A22194 | 24754380 | Pediatr Diabetes | Metabolic inflexibility and insulin resistance in obese adolescents with non-alcoholic fatty liver disease. | 2014 | Details |
A22197 | 24753460 | Nephrol Dial Transplant | Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys. | 2014 | Details |
A22199 | 24753132 | Hepatology | Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. | 2014 | Details |
A22200 | 24751397 | Aging (Albany NY) | Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease. | 2014 | Details |
A22207 | 24748893 | Hepat Mon | Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease. | 2014 | Details |
A22211 | 24746977 | Clin Nutr | Physical exercise antagonizes clinical and anatomical features characterizing Lieber-DeCarli diet-induced obesity and related metabolic disorders. | 2014 | Details |
A22213 | 24746708 | Gastroenterol Hepatol | [Non-invasive markers of fibrosis in the diagnosis of non-alcoholic fatty liver disease]. | 2014 | Details |
A22214 | 24745923 | Curr Pharm Des | Psoriasis and Vascular Risk : An Update. | 2014 | Details |
A22222 | 24742471 | J Nutr Biochem | Insight into the impact of dietary saturated fat on tissue-specific cellular processes underlying obesity-related diseases. | 2014 | Details |
A22224 | 24741297 | Clin Interv Aging | Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan. | 2014 | Details |
A22228 | 24738701 | Aliment Pharmacol Ther | Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. | 2014 | Details |
A22231 | 24737902 | Postgrad Med J | Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. | 2014 | Details |
A22235 | 24733068 | Int J Mol Sci | Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. | 2014 | Details |
A22236 | 24732091 | PLoS One | Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance. | 2014 | Details |
A22238 | 24731669 | Lancet Diabetes Endocrinol | Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. | 2014 | Details |
A22239 | 24731656 | Lancet Diabetes Endocrinol | Effects of iron overload on chronic metabolic diseases. | 2013 | Details |
A22240 | 24730643 | J Gastroenterol Hepatol | Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice. | 2014 | Details |
A22244 | 24726273 | Clin Res Hepatol Gastroenterol | Pediatric non-alcoholic fatty liver disease: recent advances. | 2014 | Details |
A22252 | 24718630 | Arch Prev Riesgos Labor | [Prevalence of non-alcoholic fatty liver disease and associated risk factors among managers from the community of Madrid]. | 2014 | Details |
A22254 | 24716593 | BMC Gastroenterol | Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease. | 2014 | Details |
A22256 | 24716162 | J Tradit Complement Med | Recent advances in the herbal treatment of non-alcoholic Fatty liver disease. | 2013 | Details |
A22263 | 24708244 | Endocrinology | GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency. | 2014 | Details |
A22265 | 24706428 | J Pediatr Endocrinol Metab | Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents. | 2014 | Details |
A22266 | 24705404 | Diabetes | Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates. | 2014 | Details |
A22268 | 24704474 | Biochem Pharmacol | Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ. | 2014 | Details |
A22271 | 24702768 | FEBS J | Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. | 2014 | Details |
A22278 | 24695736 | J Biol Chem | Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice. | 2014 | Details |
A22282 | 24692138 | Compr Physiol | Energy metabolism in the liver. | 2014 | Details |
A22287 | 24689911 | Metab Syndr Relat Disord | Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease. | 2014 | Details |
A22291 | 24689101 | J Gastrointestin Liver Dis | Recreational drugs: a new health hazard for patients with concomitant chronic liver diseases. | 2014 | Details |
A22292 | 24689094 | J Gastrointestin Liver Dis | Healthy PNPLA3 risk allele carriers present with unexpected body fat composition. A study of one thousand subjects. | 2014 | Details |
A22293 | 24688399 | ScientificWorldJournal | Ameliorative potential of Tamarindus indica on high fat diet induced nonalcoholic fatty liver disease in rats. | 2014 | Details |
A22296 | 24685236 | J Acad Nutr Diet | Vegetable consumption is linked to decreased visceral and liver fat and improved insulin resistance in overweight Latino youth. | 2014 | Details |
A22298 | 24684403 | Liver Int | Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD. | 2014 | Details |
A22299 | 24684289 | Liver Int | Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance. | 2014 | Details |
A22306 | 24677740 | Pediatr Obes | Prevalence and outcome of non-alcoholic fatty liver disease in adolescents and young adults undergoing weight loss surgery. | 2014 | Details |
A22307 | 24677249 | Hepatology | Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia. | 2014 | Details |
A22308 | 24675715 | Int J Obes (Lond) | Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease. | 2014 | Details |
A22317 | 24668763 | Hepatology | Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. | 2014 | Details |
A22319 | 24667593 | J Clin Gastroenterol | Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children. | 2015 | Details |